From Medscape Dermatology

Coverage from the

27th European Academy of Dermatology and Venereology (EADV) Congress

September 12 - 16, 2018; Paris, France

September 12 - 16, 2018 Paris, France

EADV 2018 Global Estimates Belittle Burden of Skin Diseases A patient-driven project is underway to accurately measure skin diseases around the world so that melanoma and psoriasis are not rated as being less problematic than gout.
Medscape Medical News, September 15, 2018

Conference News

EADV 2018 Dupilumab Helpful for Teens With Eczema
Medscape Medical News, September 19, 2018
EADV 2018 JAK Inhibitors Promising for Alopecia Areata
Medscape Medical News, September 17, 2018
EADV 2018 Global Estimates Belittle Burden of Skin Diseases
Medscape Medical News, September 15, 2018

EADV 2018 Risankizumab Effective for Moderate to Severe Psoriasis
Medscape Medical News, September 14, 2018
EADV 2018 Alopecia Areata Trial Results, Skin Oncology Top EADV Agenda
Medscape Medical News, August 29, 2018

Popular News from the 26th EADV Congress

For Irritating Itch, a Promising Option Under Scrutiny Investigational serlopitant afforded clinical trial patients quick relief for a variety of pruritis-characterized diseases.
Medscape Medical News, Sep 15, 2017
'Follow the Money' in Extreme Skin Cancer Care Specialists report a rise in every ultraviolet-related type of skin cancer, but controversy over excessive treatment persists.
Medscape Medical News, Sep 17, 2017
Skin-Directed Tactics Optimal for Early Cutaneous Lymphoma The many first-line treatments for this rare malignancy are being assessed in the Prospective Cutaneous Lymphoma International Prognostic Index (PROCLIPI) trial.
Medscape Medical News, Sep 18, 2017

Medscape Dermatology© WebMD, LLC

Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.

Related Coverage

All material on this website is protected by copyright, Copyright © 1994-2019 by WebMD LLC. This website also contains material copyrighted by 3rd parties.